chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 09/28, Pfizer,  dose #1 10/21, Pfizer, dose #2 1/4 COVID swab, result: detected 12/27 pt cc:  cough, fever, headache, myalgias, rhinorrhea exposure: unknown 12/28 COVID  swab, result: detected 12/28 PT: 11.3 12/28 APTT/INR: 36.1/1.01 12/28 CXR  impression: No acute cardiopulmonary disease.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram pulmonary abnormal, Blood fibrinogen increased, Brain natriuretic peptide normal, COVID-19, Chest pain
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/27, Pfizer, dose #1 04/16, Pfizer, dose #2 12/28 COVID swab, result: detected 12/20 pt cc: cough, diarrhea, exposure: unknown 1/08 pt admit Medicine cc: covid, worsening CP and SOB dx: LOS: 2 1/8 CTA PE impression: 1. No evidence for pulmonary embolus. Some individuals as detailed. 2. Multifocal areas of small peripheral predominant mixed solid and groundglass consolidation most in keeping with reported COVID 19. There is diffuse but overall mild involvement at this time. Can consider 3 month follow-up to confirm resolution given the nodular appearance in some areas. 3. Mediastinal adenopathy likely reactive. Prominent number of borderline axillary lymph nodes also favoring reactive. 1/8 abdomen u/s: Significant stool burden. Nonobstructive bowel gas pattern. No pneumoperitoneum. Excreted contrast in bilateral renal collecting systems and bladder. 1/08 1/08 PROCALCITONIN: <0.05 01/08 BNP:10.3 01/09 FIBRINOGEN:627 01/09 DDIMER: 0.6 01/09 ESR:76 1/10 FIBRINOGEN:454 1/10 DDIMBER: ESR: 60
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Diarrhoea, Dyspnoea, Faecaloma, Fibrin D dimer
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/27, Pfizer, dose #1 04/16, Pfizer, dose #2 12/28 COVID swab, result: detected 12/20 pt cc: cough, diarrhea, exposure: unknown 1/08 pt admit Medicine cc: covid, worsening CP and SOB dx: LOS: 2 1/8 CTA PE impression: 1. No evidence for pulmonary embolus. Some individuals as detailed. 2. Multifocal areas of small peripheral predominant mixed solid and groundglass consolidation most in keeping with reported COVID 19. There is diffuse but overall mild involvement at this time. Can consider 3 month follow-up to confirm resolution given the nodular appearance in some areas. 3. Mediastinal adenopathy likely reactive. Prominent number of borderline axillary lymph nodes also favoring reactive. 1/8 abdomen u/s: Significant stool burden. Nonobstructive bowel gas pattern. No pneumoperitoneum. Excreted contrast in bilateral renal collecting systems and bladder. 1/08 1/08 PROCALCITONIN: <0.05 01/08 BNP:10.3 01/09 FIBRINOGEN:627 01/09 DDIMER: 0.6 01/09 ESR:76 1/10 FIBRINOGEN:454 1/10 DDIMBER: ESR: 60
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Flatulence, Lung consolidation, Lung opacity, Lymphadenopathy, Lymphadenopathy mediastinal
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/27, Pfizer, dose #1 04/16, Pfizer, dose #2 12/28 COVID swab, result: detected 12/20 pt cc: cough, diarrhea, exposure: unknown 1/08 pt admit Medicine cc: covid, worsening CP and SOB dx: LOS: 2 1/8 CTA PE impression: 1. No evidence for pulmonary embolus. Some individuals as detailed. 2. Multifocal areas of small peripheral predominant mixed solid and groundglass consolidation most in keeping with reported COVID 19. There is diffuse but overall mild involvement at this time. Can consider 3 month follow-up to confirm resolution given the nodular appearance in some areas. 3. Mediastinal adenopathy likely reactive. Prominent number of borderline axillary lymph nodes also favoring reactive. 1/8 abdomen u/s: Significant stool burden. Nonobstructive bowel gas pattern. No pneumoperitoneum. Excreted contrast in bilateral renal collecting systems and bladder. 1/08 1/08 PROCALCITONIN: <0.05 01/08 BNP:10.3 01/09 FIBRINOGEN:627 01/09 DDIMER: 0.6 01/09 ESR:76 1/10 FIBRINOGEN:454 1/10 DDIMBER: ESR: 60
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Procalcitonin, Pulmonary mass, Red blood cell sedimentation rate increased, SARS-CoV-2 test positive, Ultrasound abdomen abnormal
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/27, Pfizer, dose #1 04/16, Pfizer, dose #2 12/28 COVID swab, result: detected 12/20 pt cc: cough, diarrhea, exposure: unknown 1/08 pt admit Medicine cc: covid, worsening CP and SOB dx: LOS: 2 1/8 CTA PE impression: 1. No evidence for pulmonary embolus. Some individuals as detailed. 2. Multifocal areas of small peripheral predominant mixed solid and groundglass consolidation most in keeping with reported COVID 19. There is diffuse but overall mild involvement at this time. Can consider 3 month follow-up to confirm resolution given the nodular appearance in some areas. 3. Mediastinal adenopathy likely reactive. Prominent number of borderline axillary lymph nodes also favoring reactive. 1/8 abdomen u/s: Significant stool burden. Nonobstructive bowel gas pattern. No pneumoperitoneum. Excreted contrast in bilateral renal collecting systems and bladder. 1/08 1/08 PROCALCITONIN: <0.05 01/08 BNP:10.3 01/09 FIBRINOGEN:627 01/09 DDIMER: 0.6 01/09 ESR:76 1/10 FIBRINOGEN:454 1/10 DDIMBER: ESR: 60
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Pain, Pain in extremity, Paraesthesia
Clinical narrative: Narrative:  04/08/21 COVID vaccine dose #1 (of1) ~12/2021 Received COVID booster at another location 01/20/2022 Patient calls, reports ~ 24 hours after his J&J booster he developed right hand tingling, pain and numbness that is starting to radiate up the arm; duration of 5 weeks no further information available at this time
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Headache, Malaise, Myalgia
Clinical narrative: Narrative: COVID infection following COVID vaccine series 04/14, Moderna ,  dose #1 05/12, Moderna , dose #2 1/3 COVID swab, result: detected 01/02 pt cc: cough, fever, headache, myalgias, rhinorrhea, sore throat exposure: unknown  01/03 pt admit ED cc: Dry cough sore throat and general malaise dx: COVID  infection LOS: 1day
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 04/14, Moderna ,  dose #1 05/12, Moderna , dose #2 1/3 COVID swab, result: detected 01/02 pt cc: cough, fever, headache, myalgias, rhinorrhea, sore throat exposure: unknown  01/03 pt admit ED cc: Dry cough sore throat and general malaise dx: COVID  infection LOS: 1day
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Chills, Cough, Fatigue
Clinical narrative: Narrative: COVID infection following COVID vaccine series 06/23, Pfizer, dose #1 07/14, Pfizer, dose #2 12/28 COVID swab, result: detected 12/26 pt cc: chills, cough, fatigue, headache, myalgias, nausea, rhinorrhea, vomiting exposure: unknown 12/28 pt admit ED cc: "fever, cough, congestion, and body aches" dx: Covid 19, Covid 19 LOS: 1 day 12/28 CXR impression: No acute pulmonary finding. 1/5 clinically resolved
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Nausea, Pain, Pyrexia
Clinical narrative: Narrative: COVID infection following COVID vaccine series 06/23, Pfizer, dose #1 07/14, Pfizer, dose #2 12/28 COVID swab, result: detected 12/26 pt cc: chills, cough, fatigue, headache, myalgias, nausea, rhinorrhea, vomiting exposure: unknown 12/28 pt admit ED cc: "fever, cough, congestion, and body aches" dx: Covid 19, Covid 19 LOS: 1 day 12/28 CXR impression: No acute pulmonary finding. 1/5 clinically resolved
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test positive, Vomiting
Clinical narrative: Narrative: COVID infection following COVID vaccine series 06/23, Pfizer, dose #1 07/14, Pfizer, dose #2 12/28 COVID swab, result: detected 12/26 pt cc: chills, cough, fatigue, headache, myalgias, nausea, rhinorrhea, vomiting exposure: unknown 12/28 pt admit ED cc: "fever, cough, congestion, and body aches" dx: Covid 19, Covid 19 LOS: 1 day 12/28 CXR impression: No acute pulmonary finding. 1/5 clinically resolved
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arrhythmia, Cardiac pacemaker insertion, Diarrhoea, Dysarthria, Hyperhidrosis
Clinical narrative: Narrative:  Patient reached out to inquire on potential booster vaccine given previous AE after the second Moderna vaccine which was administered 2/11/2021 and 3/11/2021. Patient shared previous symptoms of slurred speech, blurry vision and diaphoresis occurring 2 days after his moderna vaccine dose #2 and during a celebration in 3/2021. Symptoms were accompanied with with diarrhea and patient went to the hospital per chart review and was monitored for arrhythmia and evaluated for CVA. The patient notes that he had similar symptoms with the first dose of Moderna #1. It is noted that the patient has had similar evaluation for sinus PVC's and pacemaker alarms even when he has not had covid boosters (12/7/2021) and noted in cardiology note 12/27/2021. Given the broad differential for the patient's symptoms and the lack of clarity to what caused the patient's episodes, consulting provider recommended a shared decision making approach with the patient regarding obtaining a booster.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Ventricular extrasystoles, Vision blurred
Clinical narrative: Narrative:  Patient reached out to inquire on potential booster vaccine given previous AE after the second Moderna vaccine which was administered 2/11/2021 and 3/11/2021. Patient shared previous symptoms of slurred speech, blurry vision and diaphoresis occurring 2 days after his moderna vaccine dose #2 and during a celebration in 3/2021. Symptoms were accompanied with with diarrhea and patient went to the hospital per chart review and was monitored for arrhythmia and evaluated for CVA. The patient notes that he had similar symptoms with the first dose of Moderna #1. It is noted that the patient has had similar evaluation for sinus PVC's and pacemaker alarms even when he has not had covid boosters (12/7/2021) and noted in cardiology note 12/27/2021. Given the broad differential for the patient's symptoms and the lack of clarity to what caused the patient's episodes, consulting provider recommended a shared decision making approach with the patient regarding obtaining a booster.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray abnormal, Cough, Dizziness, Dyspnoea
Clinical narrative: Narrative: COVID infection following COVID vaccine series 05/10, Pfizer, dose #1 facility 06/01, Pfizer, dose #2 facility 12/20 COVID swab, result: detected 12/27 pt cc: cough, sore throat, feeling dizzy, nausea, SHOB exposure: unknown 12/30 pt admit ED cc: cough, sore throat, feeling dizzy, nausea, SHOB dx: Covid positive LOS: 1 day 12/30 CXR impression: Low ling volumes without acute findings in the chest. 1/6 clinically resolved
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Oropharyngeal pain, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 05/10, Pfizer, dose #1 facility 06/01, Pfizer, dose #2 facility 12/20 COVID swab, result: detected 12/27 pt cc: cough, sore throat, feeling dizzy, nausea, SHOB exposure: unknown 12/30 pt admit ED cc: cough, sore throat, feeling dizzy, nausea, SHOB dx: Covid positive LOS: 1 day 12/30 CXR impression: Low ling volumes without acute findings in the chest. 1/6 clinically resolved
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Cough, Dizziness, Dyspnoea
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/18, Pfizer, dose #1 04/08, Pfizer, dose #2 12/28 COVID swab, result: detected 12/28 pt cc: cough, headache, myalgias, dyspnea, exposure: wife/son/grandson 12/28 pt admit ED CC: shortness of breath, dizziness and general body aches DX: Covid infection los: 1 DAY 12/29 CXR Impression: No acute cardiopulmonary abnormality. Follow-up suggested for persistent or worsening symptoms.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Exposure to SARS-CoV-2, Headache, Myalgia, Pain, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/18, Pfizer, dose #1 04/08, Pfizer, dose #2 12/28 COVID swab, result: detected 12/28 pt cc: cough, headache, myalgias, dyspnea, exposure: wife/son/grandson 12/28 pt admit ED CC: shortness of breath, dizziness and general body aches DX: Covid infection los: 1 DAY 12/29 CXR Impression: No acute cardiopulmonary abnormality. Follow-up suggested for persistent or worsening symptoms.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Cough, Pain, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 05/01, Pfizer, dose #1 FACILITY 05/22, Pfizer, dose #2 FACILITY 1/2 COVID swab, result: detected 12/30 pt cc: severe body aches and cough exposure: unknown 1/02 CXR IMPRESSION: No acute cardiopulmonary disease 1/02 pt admit ED cc: severe body aches and cough dx: Covid 19 LOS: 1 day
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Pain, Pyrexia, Respiratory tract congestion
Clinical narrative: Narrative:  COVID infection following COVID vaccine 03/31, Pfizer, dose #1 04/21, Pfizer, dose #2 12/28 COVID swab, result: detected 12/26 pt cc: cough, fever, congestion and body aches for 2 days exposure: unknown 12/28 pt admit ED CC: cough, fever, congestion and body aches DX: Covid infection LOS:1 day
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine 03/31, Pfizer, dose #1 04/21, Pfizer, dose #2 12/28 COVID swab, result: detected 12/26 pt cc: cough, fever, congestion and body aches for 2 days exposure: unknown 12/28 pt admit ED CC: cough, fever, congestion and body aches DX: Covid infection LOS:1 day
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Oropharyngeal pain, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 07/28 Janssen, dose #1 12/28 COVID swab, result: detected 12/28 pt cc: sore throat x 2 weeks and dry cough. exposure: unknown 12/28 pt admit ED cc: sore throat x 2 weeks and dry cough. dx: COVID-19 LOS: 1 DAY
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Cough, SARS-CoV-2 test positive, Sinus congestion
Clinical narrative: Narrative: COVID infection following COIVD vaccine series 05/06, Pfizer, dose #1 06/03, Pfizer, dose #2 12/30 COVID swab, result: detected 12/28 pt cc: sinus congestion and dry cough exposure: unknown 12/30 CXR impression: No acute abnormality. 12/30 pt admit ED cc: sinus congestion and dry cought dx: COIVD LOS: 1 day
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Myalgia, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID VACCINE SERIES 05/10 Janssen, dose #1 12/28 COVID swab, result: detected 12/28 pt cc: chills myalgias exposure: unknown
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Exposure to SARS-CoV-2, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/09, Pfizer,  dose #1 03/30, Pfizer, dose #2 12/22, Pfizer, dose #3 12/28 COVID swab, result:  detected 12/23 pt cc: exposure: unknown 12/28 pt admit to ED cc: request swab  dx:COVID EXPOSURE LOS: 1 day
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Blood lactic acid, COVID-19, Chest X-ray normal, Chills, Cough
Clinical narrative: Narrative: COVID infection following COVID vaccine series 07/01, Pfizer, dose #1 07/22, Pfizer, dose #2 12/28 COVID swab, result: detected 12/27 pt cc: chills, cough, diarrhea, fatigue, fever, dyspnea exposure: unknown 12/29 ESR: 11 12/29 LACTIC ACID: 1.59 12/29 CXR impression: No pleural effusion or pneumothorax. No pulmonary edema or focal consolidation. Normal cardiomediastinal silhouette.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Dyspnoea, Fatigue, Pyrexia, Red blood cell sedimentation rate normal
Clinical narrative: Narrative: COVID infection following COVID vaccine series 07/01, Pfizer, dose #1 07/22, Pfizer, dose #2 12/28 COVID swab, result: detected 12/27 pt cc: chills, cough, diarrhea, fatigue, fever, dyspnea exposure: unknown 12/29 ESR: 11 12/29 LACTIC ACID: 1.59 12/29 CXR impression: No pleural effusion or pneumothorax. No pulmonary edema or focal consolidation. Normal cardiomediastinal silhouette.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 07/01, Pfizer, dose #1 07/22, Pfizer, dose #2 12/28 COVID swab, result: detected 12/27 pt cc: chills, cough, diarrhea, fatigue, fever, dyspnea exposure: unknown 12/29 ESR: 11 12/29 LACTIC ACID: 1.59 12/29 CXR impression: No pleural effusion or pneumothorax. No pulmonary edema or focal consolidation. Normal cardiomediastinal silhouette.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative:  1st Moderna vaccine: 2/16/2021 2nd moderna vaccine: 3/16/2021 covid positive: 1/26/2022 patient with current hospital say 1/26/2022 to present
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dry throat, SARS-CoV-2 test positive, Throat irritation
Clinical narrative: Narrative: COVID infection following COVID vaccine series 07/15 Janssen, dose #1 12/30 COVID swab, result: detected 12/28 pt cc: Itchy, dry throat exposure: unknown 12/30 pt admit to ED cc: Itchy, dry throat dx: COVID 19 LOS: 1 day
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Chest pain, Cough, Headache
Clinical narrative: Narrative: COVID infection following COVID vaccine series 07/29, Pfizer dose #1 08/19, Pfizer, dose #2 01/03 COVID swab, result: detected 12/27 pt cc: headache, fever, body aches, cough, and chest pain exposure: unknown 12/28 pt admit ED cc: headache, fever, body aches, cough, and chest pain dx: COVID+ LOS: 1 day 12/28 CXR impression: No acute thoracic abnormalities.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 07/29, Pfizer dose #1 08/19, Pfizer, dose #2 01/03 COVID swab, result: detected 12/27 pt cc: headache, fever, body aches, cough, and chest pain exposure: unknown 12/28 pt admit ED cc: headache, fever, body aches, cough, and chest pain dx: COVID+ LOS: 1 day 12/28 CXR impression: No acute thoracic abnormalities.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, COVID-19, Chest X-ray normal, Cough, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series and after previous COVID infection 03/09, Pfizer, dose #1 03/31, Pfizer, dose #2 11/02, Pfizer, dose #3 12/30 COVID swab, result: detected 1/8 COVID swab, result: detected 02/24 pt cc: Cough, Upper/mid back pain, exposure: unknown 01/03 pt cc: no symptoms exposure: unknown 02/24 pt admit to ED cc: Cough, Upper/mid back pain, dx COVID 19, upper back pain, LOS: 1 day 2/24 cxr impression: No acute cardiopulmonary process.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Inappropriate schedule of product administration, Myalgia, Rhinorrhoea
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/23, Pfizer, dose #1 02/16, Pfizer, dose #2 1/15, Pfizer, dose #3 12/29 COVID swab, result: detected 12/28 pt cc: cough, myalgias, rhinorrhea, exposure: unknown 1/4 clinically resolved
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/23, Pfizer, dose #1 02/16, Pfizer, dose #2 1/15, Pfizer, dose #3 12/29 COVID swab, result: detected 12/28 pt cc: cough, myalgias, rhinorrhea, exposure: unknown 1/4 clinically resolved
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Cough, SARS-CoV-2 test positive, Wheezing
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 09/13, Pfizer, dose #1 10/04, Pfizer, dose #2 12/29 COVID swab, result: detected 12/27 pt cc: cough and wheezing exposure: unknown 12/29 pt admit ED cc: cough and wheezing dx: COVID LOS: 1 day
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Oropharyngeal pain, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 04/06 Janssen, dose #1 12/30 COVID swab, result: detected 12/30 pt cc: sore throat and congestion exposure: unknown 12:30 CXR impression: No acute cardiopulmonary disease.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Fatigue, Musculoskeletal chest pain, Pain
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/17, Pfizer, dose #1 04/07, Pfizer, dose #2 1/2 COVID swab, result: detected 01/02 pt cc: fatigue, fever exposure: unknown 01/02 CXR IMPRESSION: No acute productive cough, fatiue. body aches, and bilateral anterior lower chest wall pain. dx:  Covid illness; LOS; 1 day
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Productive cough, Pyrexia, SARS-CoV-2 test positive, Troponin I normal
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/17, Pfizer, dose #1 04/07, Pfizer, dose #2 1/2 COVID swab, result: detected 01/02 pt cc: fatigue, fever exposure: unknown 01/02 CXR IMPRESSION: No acute productive cough, fatiue. body aches, and bilateral anterior lower chest wall pain. dx:  Covid illness; LOS; 1 day
Age: 94.0
Sex: M
Vaccine: COVID19
Symptoms: Arteriogram coronary abnormal, Asthenia, Atypical pneumonia, Blood fibrinogen increased, C-reactive protein increased
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/12, Pfizer, dose #1 03/05, Pfizer, dose #2 12/30 COVID swab, result: detected 01/4 pt cc: weakness, chills, dizzy exposure: unknown 1/7 CXR impression: Left basilar  pneumonia . 1/7 pt admit to Medicine cc: weak, not eating or drinking dx: COVID 19 infection LOS: 13 days 1/7 TROPNIN 1: 0.019 1/7CRP: 3.027 1/7 PROCALCITONIN: <0.05 1/08 FIBRINOGEN: 420 1/9 FIBRINOGEN: 420 1/9  DDIMER:5.13 1/9 ESR: 36 1/9 CT LTD OR LOCALIZED impression: Evaluation for pulmonary embolism could not be performed secondary to left arm contrast extravasation/infiltration-correlate with neurovascular examination of the  left upper extremity. Note is made of a left eccentric/multifocal pneumonia which may be seen with COVID-19, though alternative processes are not excluded. 1/9 CT A PE impression: 1. Technically inadequate examination for the evaluation of pulmonary embolism. There is no enhancement of the pulmonary arterial system. Contrast has extravasated into the left upper extremity and the intravascular contrast is predominantly within the systemic arterial circulation. 2. Bilateral groundglass opacities, left more than right, which is suggestive of atypical infection and is likely related to the patient's known Covid 19 pneumonia. 1/10 FIBRINOGEN: 405 1/10 DDIWR: 3.52 1/10 ESR: 23 1/10 SARS-COV-2 igG: 4.58 1 10 SARS-COV-2 total AB: >2500.0 1/10 US DOPPLER LOW EXT VEIN BILATERAL impression: Negative examination for thrombosis in the bilateral lower extremity veins listed above. 1/11 DI)IVIER: 2.32 1/11 ESR: 39 1/11 CXR impression: 1/11 CT A PE impression: l. Subsegmental pulmonary emboli within the right lower lobe is identified. No central or segmental embolus is seen. There is no evidence of right heart strain. 2. No significant change in the opacities scattered throughout bilateral lungs, more on the left than the right. These findings likely represent atypical infection related to the patient's known Covid 19 pneumonia. 3. Redemonstration of a partially visualized hypodense lesion within the right upper quadrant which could be arising from the kidney. Can obtain dedicated abdominal imaging for further evaluation. 1/12 ESR: 29 1/12 DDIMER: 2.94
Age: 94.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Chills, Dizziness
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/12, Pfizer, dose #1 03/05, Pfizer, dose #2 12/30 COVID swab, result: detected 01/4 pt cc: weakness, chills, dizzy exposure: unknown 1/7 CXR impression: Left basilar  pneumonia . 1/7 pt admit to Medicine cc: weak, not eating or drinking dx: COVID 19 infection LOS: 13 days 1/7 TROPNIN 1: 0.019 1/7CRP: 3.027 1/7 PROCALCITONIN: <0.05 1/08 FIBRINOGEN: 420 1/9 FIBRINOGEN: 420 1/9  DDIMER:5.13 1/9 ESR: 36 1/9 CT LTD OR LOCALIZED impression: Evaluation for pulmonary embolism could not be performed secondary to left arm contrast extravasation/infiltration-correlate with neurovascular examination of the  left upper extremity. Note is made of a left eccentric/multifocal pneumonia which may be seen with COVID-19, though alternative processes are not excluded. 1/9 CT A PE impression: 1. Technically inadequate examination for the evaluation of pulmonary embolism. There is no enhancement of the pulmonary arterial system. Contrast has extravasated into the left upper extremity and the intravascular contrast is predominantly within the systemic arterial circulation. 2. Bilateral groundglass opacities, left more than right, which is suggestive of atypical infection and is likely related to the patient's known Covid 19 pneumonia. 1/10 FIBRINOGEN: 405 1/10 DDIWR: 3.52 1/10 ESR: 23 1/10 SARS-COV-2 igG: 4.58 1 10 SARS-COV-2 total AB: >2500.0 1/10 US DOPPLER LOW EXT VEIN BILATERAL impression: Negative examination for thrombosis in the bilateral lower extremity veins listed above. 1/11 DI)IVIER: 2.32 1/11 ESR: 39 1/11 CXR impression: 1/11 CT A PE impression: l. Subsegmental pulmonary emboli within the right lower lobe is identified. No central or segmental embolus is seen. There is no evidence of right heart strain. 2. No significant change in the opacities scattered throughout bilateral lungs, more on the left than the right. These findings likely represent atypical infection related to the patient's known Covid 19 pneumonia. 3. Redemonstration of a partially visualized hypodense lesion within the right upper quadrant which could be arising from the kidney. Can obtain dedicated abdominal imaging for further evaluation. 1/12 ESR: 29 1/12 DDIMER: 2.94
Age: 94.0
Sex: M
Vaccine: COVID19
Symptoms: Fibrin D dimer, Fluid intake reduced, Hypophagia, Infection, Infusion site extravasation
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/12, Pfizer, dose #1 03/05, Pfizer, dose #2 12/30 COVID swab, result: detected 01/4 pt cc: weakness, chills, dizzy exposure: unknown 1/7 CXR impression: Left basilar  pneumonia . 1/7 pt admit to Medicine cc: weak, not eating or drinking dx: COVID 19 infection LOS: 13 days 1/7 TROPNIN 1: 0.019 1/7CRP: 3.027 1/7 PROCALCITONIN: <0.05 1/08 FIBRINOGEN: 420 1/9 FIBRINOGEN: 420 1/9  DDIMER:5.13 1/9 ESR: 36 1/9 CT LTD OR LOCALIZED impression: Evaluation for pulmonary embolism could not be performed secondary to left arm contrast extravasation/infiltration-correlate with neurovascular examination of the  left upper extremity. Note is made of a left eccentric/multifocal pneumonia which may be seen with COVID-19, though alternative processes are not excluded. 1/9 CT A PE impression: 1. Technically inadequate examination for the evaluation of pulmonary embolism. There is no enhancement of the pulmonary arterial system. Contrast has extravasated into the left upper extremity and the intravascular contrast is predominantly within the systemic arterial circulation. 2. Bilateral groundglass opacities, left more than right, which is suggestive of atypical infection and is likely related to the patient's known Covid 19 pneumonia. 1/10 FIBRINOGEN: 405 1/10 DDIWR: 3.52 1/10 ESR: 23 1/10 SARS-COV-2 igG: 4.58 1 10 SARS-COV-2 total AB: >2500.0 1/10 US DOPPLER LOW EXT VEIN BILATERAL impression: Negative examination for thrombosis in the bilateral lower extremity veins listed above. 1/11 DI)IVIER: 2.32 1/11 ESR: 39 1/11 CXR impression: 1/11 CT A PE impression: l. Subsegmental pulmonary emboli within the right lower lobe is identified. No central or segmental embolus is seen. There is no evidence of right heart strain. 2. No significant change in the opacities scattered throughout bilateral lungs, more on the left than the right. These findings likely represent atypical infection related to the patient's known Covid 19 pneumonia. 3. Redemonstration of a partially visualized hypodense lesion within the right upper quadrant which could be arising from the kidney. Can obtain dedicated abdominal imaging for further evaluation. 1/12 ESR: 29 1/12 DDIMER: 2.94
Age: 94.0
Sex: M
Vaccine: COVID19
Symptoms: Lung opacity, Peritoneal lesion, Pneumonia, Procalcitonin, Pulmonary embolism
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/12, Pfizer, dose #1 03/05, Pfizer, dose #2 12/30 COVID swab, result: detected 01/4 pt cc: weakness, chills, dizzy exposure: unknown 1/7 CXR impression: Left basilar  pneumonia . 1/7 pt admit to Medicine cc: weak, not eating or drinking dx: COVID 19 infection LOS: 13 days 1/7 TROPNIN 1: 0.019 1/7CRP: 3.027 1/7 PROCALCITONIN: <0.05 1/08 FIBRINOGEN: 420 1/9 FIBRINOGEN: 420 1/9  DDIMER:5.13 1/9 ESR: 36 1/9 CT LTD OR LOCALIZED impression: Evaluation for pulmonary embolism could not be performed secondary to left arm contrast extravasation/infiltration-correlate with neurovascular examination of the  left upper extremity. Note is made of a left eccentric/multifocal pneumonia which may be seen with COVID-19, though alternative processes are not excluded. 1/9 CT A PE impression: 1. Technically inadequate examination for the evaluation of pulmonary embolism. There is no enhancement of the pulmonary arterial system. Contrast has extravasated into the left upper extremity and the intravascular contrast is predominantly within the systemic arterial circulation. 2. Bilateral groundglass opacities, left more than right, which is suggestive of atypical infection and is likely related to the patient's known Covid 19 pneumonia. 1/10 FIBRINOGEN: 405 1/10 DDIWR: 3.52 1/10 ESR: 23 1/10 SARS-COV-2 igG: 4.58 1 10 SARS-COV-2 total AB: >2500.0 1/10 US DOPPLER LOW EXT VEIN BILATERAL impression: Negative examination for thrombosis in the bilateral lower extremity veins listed above. 1/11 DI)IVIER: 2.32 1/11 ESR: 39 1/11 CXR impression: 1/11 CT A PE impression: l. Subsegmental pulmonary emboli within the right lower lobe is identified. No central or segmental embolus is seen. There is no evidence of right heart strain. 2. No significant change in the opacities scattered throughout bilateral lungs, more on the left than the right. These findings likely represent atypical infection related to the patient's known Covid 19 pneumonia. 3. Redemonstration of a partially visualized hypodense lesion within the right upper quadrant which could be arising from the kidney. Can obtain dedicated abdominal imaging for further evaluation. 1/12 ESR: 29 1/12 DDIMER: 2.94
Age: 94.0
Sex: M
Vaccine: COVID19
Symptoms: Red blood cell sedimentation rate increased, SARS-CoV-2 antibody test, SARS-CoV-2 test positive, Troponin I normal, Ultrasound Doppler normal
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/12, Pfizer, dose #1 03/05, Pfizer, dose #2 12/30 COVID swab, result: detected 01/4 pt cc: weakness, chills, dizzy exposure: unknown 1/7 CXR impression: Left basilar  pneumonia . 1/7 pt admit to Medicine cc: weak, not eating or drinking dx: COVID 19 infection LOS: 13 days 1/7 TROPNIN 1: 0.019 1/7CRP: 3.027 1/7 PROCALCITONIN: <0.05 1/08 FIBRINOGEN: 420 1/9 FIBRINOGEN: 420 1/9  DDIMER:5.13 1/9 ESR: 36 1/9 CT LTD OR LOCALIZED impression: Evaluation for pulmonary embolism could not be performed secondary to left arm contrast extravasation/infiltration-correlate with neurovascular examination of the  left upper extremity. Note is made of a left eccentric/multifocal pneumonia which may be seen with COVID-19, though alternative processes are not excluded. 1/9 CT A PE impression: 1. Technically inadequate examination for the evaluation of pulmonary embolism. There is no enhancement of the pulmonary arterial system. Contrast has extravasated into the left upper extremity and the intravascular contrast is predominantly within the systemic arterial circulation. 2. Bilateral groundglass opacities, left more than right, which is suggestive of atypical infection and is likely related to the patient's known Covid 19 pneumonia. 1/10 FIBRINOGEN: 405 1/10 DDIWR: 3.52 1/10 ESR: 23 1/10 SARS-COV-2 igG: 4.58 1 10 SARS-COV-2 total AB: >2500.0 1/10 US DOPPLER LOW EXT VEIN BILATERAL impression: Negative examination for thrombosis in the bilateral lower extremity veins listed above. 1/11 DI)IVIER: 2.32 1/11 ESR: 39 1/11 CXR impression: 1/11 CT A PE impression: l. Subsegmental pulmonary emboli within the right lower lobe is identified. No central or segmental embolus is seen. There is no evidence of right heart strain. 2. No significant change in the opacities scattered throughout bilateral lungs, more on the left than the right. These findings likely represent atypical infection related to the patient's known Covid 19 pneumonia. 3. Redemonstration of a partially visualized hypodense lesion within the right upper quadrant which could be arising from the kidney. Can obtain dedicated abdominal imaging for further evaluation. 1/12 ESR: 29 1/12 DDIMER: 2.94
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Patient tested positive for COVID-19 and was hospitalized despite full vaccination. Last vaccine was on 07/02/2021 which was the second injection of Moderna. No booster documented to date
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Cough, Dehydration, Fatigue
Clinical narrative: Narrative: COVID infection following COVID vaccine series 07/27, Pfizer, does #1 08/24, Pfizer, dose #2 12/28 COVID swab, result: detected 12/25 pt cc: cough, fatigue, fever, myalgias, rhinorrhea, sore throat exposure: unknow 12/28 pt admitted ED cc: "I have fever, cough, body aches and a sore throat" dx: Covid 19, Dehydration, Hypokalemia LOS: 1 DAY 12/28 CXR impression: No acute pulmonary finding. 12/31 clinically resolved
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Hypokalaemia, Inappropriate schedule of product administration, Myalgia, Oropharyngeal pain, Rhinorrhoea
Clinical narrative: Narrative: COVID infection following COVID vaccine series 07/27, Pfizer, does #1 08/24, Pfizer, dose #2 12/28 COVID swab, result: detected 12/25 pt cc: cough, fatigue, fever, myalgias, rhinorrhea, sore throat exposure: unknow 12/28 pt admitted ED cc: "I have fever, cough, body aches and a sore throat" dx: Covid 19, Dehydration, Hypokalemia LOS: 1 DAY 12/28 CXR impression: No acute pulmonary finding. 12/31 clinically resolved
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative:  1st dose moderna 2-11-21 2nd dose moderna 3-12-21 booster dose moderna 12-6-21 covid positive 1-9-22 resulting in hospital stay
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Chest X-ray normal, Cough, Inappropriate schedule of product administration, Oropharyngeal pain
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/11, Pfizer,  dose #1 04/07, Pfizer, dose #2 11/23, Pfizer, dose #3 01/03 COVID swab, result: detected 12/23 pt cc: URI symptoms, sore throat, runny nose, congestion, mild  cough exposure: unknown 01/03 pt admit ED cc: URI symptoms, sore throat, runny  nose, congestion, mild cough dx: COVID-19+ LOS: 1 day 01/03 CXR IMPPRESSION: No radiographic evidence of acute cardiopulmonary disease.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test positive, Upper respiratory tract infection
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/11, Pfizer,  dose #1 04/07, Pfizer, dose #2 11/23, Pfizer, dose #3 01/03 COVID swab, result: detected 12/23 pt cc: URI symptoms, sore throat, runny nose, congestion, mild  cough exposure: unknown 01/03 pt admit ED cc: URI symptoms, sore throat, runny  nose, congestion, mild cough dx: COVID-19+ LOS: 1 day 01/03 CXR IMPPRESSION: No radiographic evidence of acute cardiopulmonary disease.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Exposure to SARS-CoV-2, Myalgia, Oropharyngeal pain
Clinical narrative: Narrative: COVID infection following COVID vaccine series 04/23, Pfizer, dose #1 (NON-FACILITY) local county DOH 05/09, Pfizer, dose #2 (NON-FACILITY) local county DOH 12/27 COVID swab, result: detected 12/27 pt cc: cough myalgias, rhinorrhea, sore throat exposure: wife
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 04/23, Pfizer, dose #1 (NON-FACILITY) local county DOH 05/09, Pfizer, dose #2 (NON-FACILITY) local county DOH 12/27 COVID swab, result: detected 12/27 pt cc: cough myalgias, rhinorrhea, sore throat exposure: wife
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Chills, Cough, Pain
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/02, Pfizer, dose #1 02/22, Pfizer, dose #2 12/30 COVID swab, result: detected 1/10 COVID swab, result: detected 12/27 pt cc: cough/congestion/body aches/subjective fever/chills exposure: unknown 12/30 pt admit ED cc: cough/congestions/body aches/subjective fever/chills dx: Coronavirus LOS: 1 day 12/30 CXR impression: No acute abnormality.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/02, Pfizer, dose #1 02/22, Pfizer, dose #2 12/30 COVID swab, result: detected 1/10 COVID swab, result: detected 12/27 pt cc: cough/congestion/body aches/subjective fever/chills exposure: unknown 12/30 pt admit ED cc: cough/congestions/body aches/subjective fever/chills dx: Coronavirus LOS: 1 day 12/30 CXR impression: No acute abnormality.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Activated partial thromboplastin time prolonged, COVID-19, Chest X-ray normal, Cough, Headache
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/18, Pfizer dose #1 04/05, Pfizer, dose #2 12/30 COVID swab, result: detected 12/24 pt cc: HEADACHE exposure: unknown 12/30 pt admit ED cc: body aches, cough and fever dx: COVID  Infection LOS: 1 day 12/30 PT: 11.9 12/30 APTT: 33.3 12/30 INR: 1/06 12/30 CXR Impression: no acute thoracic abnormalities. 1/3 clinically resolved
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: International normalised ratio, Pain, Prothrombin time prolonged, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/18, Pfizer dose #1 04/05, Pfizer, dose #2 12/30 COVID swab, result: detected 12/24 pt cc: HEADACHE exposure: unknown 12/30 pt admit ED cc: body aches, cough and fever dx: COVID  Infection LOS: 1 day 12/30 PT: 11.9 12/30 APTT: 33.3 12/30 INR: 1/06 12/30 CXR Impression: no acute thoracic abnormalities. 1/3 clinically resolved
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray, Headache, Malaise, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 04/11 Janssen, dose #1 (hospital) 12/06 Pfizer, dose #2 1/5 COVID swab, result: detected 12/28 pt cc: malaise, wheezing, headache, sinus congestion exposure; unknown 12/30 pt admit ED cc: malaise, wheezing, headache, sinus congestion dx: COVID LOS: 1 DAY 12/30 CXR impression: 1. No pneumonia. 2. Possible right pulmonary nodule. Recommend PA and lateral chest radiograph in the nonacute setting.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Sinus congestion, Wheezing
Clinical narrative: Narrative: COVID infection following COVID vaccine series 04/11 Janssen, dose #1 (hospital) 12/06 Pfizer, dose #2 1/5 COVID swab, result: detected 12/28 pt cc: malaise, wheezing, headache, sinus congestion exposure; unknown 12/30 pt admit ED cc: malaise, wheezing, headache, sinus congestion dx: COVID LOS: 1 DAY 12/30 CXR impression: 1. No pneumonia. 2. Possible right pulmonary nodule. Recommend PA and lateral chest radiograph in the nonacute setting.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Cough, Dyspnoea, Ear discomfort
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/22, Pfizer, dos #1 03/15, Pfizer, dose #2 12/16 COVID swab, result: not detected 12/29 COVID swab, result: detected 12/28 pt cc: cough, fever, medication, myalgias, sore throat exposure: unknown 01/11 pt admit to ED cc: cough, ear and sinus pressure, and mild shortness of breath dx; COVID infection LOS: 1 day clinically resolved 1/11 CXR impression: No acute infiltrate.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Oropharyngeal pain, Paranasal sinus discomfort, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/22, Pfizer, dos #1 03/15, Pfizer, dose #2 12/16 COVID swab, result: not detected 12/29 COVID swab, result: detected 12/28 pt cc: cough, fever, medication, myalgias, sore throat exposure: unknown 01/11 pt admit to ED cc: cough, ear and sinus pressure, and mild shortness of breath dx; COVID infection LOS: 1 day clinically resolved 1/11 CXR impression: No acute infiltrate.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Exposure to SARS-CoV-2, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series unknown date and  location of vaccine 12/29 COVID swab, result: detected 12/29 pt cc: exposure:  family 12/29 pt admit ED cc: exposure to COVID dx: COVID EXPOSURE LOS:  I day
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Blood fibrinogen normal, COVID-19, Chest X-ray normal, Cough
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 07/08, Pfizer,  dose #1 07/29, Pfizer, dose #2 09/07, Pfizer, dose #3 1/13 COVID swab, result:  detected 12/30 COVID swab, result: detected 12/30 pt cc: cough, fatigue, sore  throat exposure: unknown 1/13 CXR IMPRESSION: No frank pneumonic  infiltrate. 1/20 CXR IMPRESSION: No acute cardiopulmonary disease. 1/20 pt  admit medicine cc: Shortness of breath and back pain dx: COVID19 viral  syndrome, Complicated Bacterial UTI LOS: 2 days 1/22 FIBRINOGEN: 271 1/22  DDIMER: 1.52 1 22 PROCALCITONIN: 0.52
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Fibrin D dimer increased, Oropharyngeal pain, Procalcitonin
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 07/08, Pfizer,  dose #1 07/29, Pfizer, dose #2 09/07, Pfizer, dose #3 1/13 COVID swab, result:  detected 12/30 COVID swab, result: detected 12/30 pt cc: cough, fatigue, sore  throat exposure: unknown 1/13 CXR IMPRESSION: No frank pneumonic  infiltrate. 1/20 CXR IMPRESSION: No acute cardiopulmonary disease. 1/20 pt  admit medicine cc: Shortness of breath and back pain dx: COVID19 viral  syndrome, Complicated Bacterial UTI LOS: 2 days 1/22 FIBRINOGEN: 271 1/22  DDIMER: 1.52 1 22 PROCALCITONIN: 0.52
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 07/08, Pfizer,  dose #1 07/29, Pfizer, dose #2 09/07, Pfizer, dose #3 1/13 COVID swab, result:  detected 12/30 COVID swab, result: detected 12/30 pt cc: cough, fatigue, sore  throat exposure: unknown 1/13 CXR IMPRESSION: No frank pneumonic  infiltrate. 1/20 CXR IMPRESSION: No acute cardiopulmonary disease. 1/20 pt  admit medicine cc: Shortness of breath and back pain dx: COVID19 viral  syndrome, Complicated Bacterial UTI LOS: 2 days 1/22 FIBRINOGEN: 271 1/22  DDIMER: 1.52 1 22 PROCALCITONIN: 0.52
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, COVID-19, Chest X-ray normal, Chills, Cough
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/10, Pfizer, dose #1 03/03, Pfizer, dose #2 12/31 COVID swab, result: detected 12/21 pt cc: fevers, chills, bodyaches, mild cough, back pain. exposure: unknown 12/31 CXR impression: No acute cardiopulmonary disease. 12/31 SPINE CERVICAL impression: Severe cervical spondylosis is present worst at C5-6 and C6-7. Negative for scoliosis. The C1-C2 relationship is maintained. No acute fracture or dislocation is seen, however if there is a history of trauma, a CT of the cervical spine is recommended is distended care. 12/31 SARS-COV2 TOTAL AB: 1929 12/31 SARS-COV IGG 0.01 12/31 TROPONIN I: 0.190 12/31 DDIMER; 0.43 12/31 TROPONIN I: 0.177 12/31 Pt admit to Medicine cc: Upper back pain dx: Upper Back/Neck Pain- symptoms present since becoming sick with COVID019, likely MSK etiology in setting of coughing LOS 3 days
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Fibrin D dimer, Imaging procedure abnormal, Malaise, Musculoskeletal pain, Neck pain
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/10, Pfizer, dose #1 03/03, Pfizer, dose #2 12/31 COVID swab, result: detected 12/21 pt cc: fevers, chills, bodyaches, mild cough, back pain. exposure: unknown 12/31 CXR impression: No acute cardiopulmonary disease. 12/31 SPINE CERVICAL impression: Severe cervical spondylosis is present worst at C5-6 and C6-7. Negative for scoliosis. The C1-C2 relationship is maintained. No acute fracture or dislocation is seen, however if there is a history of trauma, a CT of the cervical spine is recommended is distended care. 12/31 SARS-COV2 TOTAL AB: 1929 12/31 SARS-COV IGG 0.01 12/31 TROPONIN I: 0.190 12/31 DDIMER; 0.43 12/31 TROPONIN I: 0.177 12/31 Pt admit to Medicine cc: Upper back pain dx: Upper Back/Neck Pain- symptoms present since becoming sick with COVID019, likely MSK etiology in setting of coughing LOS 3 days
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pyrexia, SARS-CoV-2 antibody test, SARS-CoV-2 test positive, Spinal osteoarthritis
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/10, Pfizer, dose #1 03/03, Pfizer, dose #2 12/31 COVID swab, result: detected 12/21 pt cc: fevers, chills, bodyaches, mild cough, back pain. exposure: unknown 12/31 CXR impression: No acute cardiopulmonary disease. 12/31 SPINE CERVICAL impression: Severe cervical spondylosis is present worst at C5-6 and C6-7. Negative for scoliosis. The C1-C2 relationship is maintained. No acute fracture or dislocation is seen, however if there is a history of trauma, a CT of the cervical spine is recommended is distended care. 12/31 SARS-COV2 TOTAL AB: 1929 12/31 SARS-COV IGG 0.01 12/31 TROPONIN I: 0.190 12/31 DDIMER; 0.43 12/31 TROPONIN I: 0.177 12/31 Pt admit to Medicine cc: Upper back pain dx: Upper Back/Neck Pain- symptoms present since becoming sick with COVID019, likely MSK etiology in setting of coughing LOS 3 days
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Troponin I increased
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/10, Pfizer, dose #1 03/03, Pfizer, dose #2 12/31 COVID swab, result: detected 12/21 pt cc: fevers, chills, bodyaches, mild cough, back pain. exposure: unknown 12/31 CXR impression: No acute cardiopulmonary disease. 12/31 SPINE CERVICAL impression: Severe cervical spondylosis is present worst at C5-6 and C6-7. Negative for scoliosis. The C1-C2 relationship is maintained. No acute fracture or dislocation is seen, however if there is a history of trauma, a CT of the cervical spine is recommended is distended care. 12/31 SARS-COV2 TOTAL AB: 1929 12/31 SARS-COV IGG 0.01 12/31 TROPONIN I: 0.190 12/31 DDIMER; 0.43 12/31 TROPONIN I: 0.177 12/31 Pt admit to Medicine cc: Upper back pain dx: Upper Back/Neck Pain- symptoms present since becoming sick with COVID019, likely MSK etiology in setting of coughing LOS 3 days